Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-02-10

Clinical Trial Update: Study of a Bone Assessment Technique, Bone Mineral Analyser, Concerning the Prediction of Improvement in Bone Status After an Infusion of Zoledronic Acid in Osteoporotic Women [NA]

View source ↗

Summary

This document notes the withdrawal of a clinical trial evaluating a bone assessment technique to predict improvement in bone status after zoledronic acid infusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Osteoporosis | NA | Status: WITHDRAWN